4//SEC Filing
STOKELY DAN 4
Accession 0001415889-21-001543
CIK 0001411906other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 6:35 PM ET
Size
8.5 KB
Accession
0001415889-21-001543
Insider Transaction Report
Form 4
STOKELY DAN
CFO
Transactions
- Exercise/Conversion
Common Stock
2021-03-16$0.43/sh+40,000$17,200→ 68,315 total - Sale
Common Stock
2021-03-16$1.83/sh−40,000$73,048→ 28,315 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-16−40,000→ 318,000 totalExercise: $0.43Exp: 2029-08-20→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Options were granted and previously reported on a Form 4 dated August 22, 2019, where 50% of the stock option award vests and becomes exerciserable on the date of grant, the remaining 50% of the stock option award vests and becomes exerciserable on July 31, 2020.
Documents
Issuer
Ampio Pharmaceuticals, Inc.
CIK 0001411906
Entity typeother
Related Parties
1- filerCIK 0001277543
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 6:35 PM ET
- Size
- 8.5 KB